CONCUSSION DRUG STUDY SHOWS POSITIVE EARLY RESULTS
BioPharma
United States Chris Nowinski Michael Wyand Richard Sherman Michael Rippee Concussion Legacy Foundation
Source: biopharmadive.com
📰 Michael Rippee News
Michael Rippee News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Michael Rippee. Real-time updates on events, politics, business and more.
OXEIA ANNOUNCES POSITIVE INTERIM RESULTS OF PHASE 2 TRIAL
Phase 2 clinical trial for OXE103 for the treatment of concussion is being conducted at University of Kansas Medical Center, Kansas City, KansasEnrolling...
Kansas Medical Center United States University Of Kansas Medical Center Kansas City Michael Wyand Michael Rippee
Source: globenewswire.com
OXEIA ANNOUNCES POSITIVE INTERIM RESULTS OF PHASE 2 TRIAL FOR OXE103 FOR THE TREATMENT OF CONCUSSIONS
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Kansas Medical Center United States University Of Kansas Medical Center Kansas City Lindsey Mcclelland Michael Wyand
Source: apnews.com